Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2024

Long ME, Koirala S, Sloan S, Brown-Burke F, Weigel C, Villagomez L, et al. Resistance to PRMT5-targeted therapy in mantle cell lymphoma. Blood Adv. 2024;8(1):150-163.

Hu S, Graham RP, Choi W-, Wen KW, Putra J, Chen W, et al. Clinicopathologic Features of Gastrointestinal Tract Langerhans Cell Histiocytosis. Mod Pathol. 2024;37(9):100543.

Omar M, Xu Z, Rand SB, Alexanderani MK, Salles DC, Valencia I, et al. Semi-Supervised, Attention-Based Deep Learning for Predicting TMPRSS2:ERG Fusion Status in Prostate Cancer Using Whole Slide Images. Mol Cancer Res. 2024;22(4):347-359.

Deochand DK, Dacic M, Bale MJ, Daman AW, Josefowicz SZ, Oliver D, et al. Mechanisms of Epigenomic and Functional Convergence Between Glucocorticoid- and IL4-Driven Macrophage Programming. bioRxiv. 2024.

Javdan B, Marwaha S, Magro C, Wassef C. Pink Papules on the Cheek. Cutis. 2024;113(1):10-17.

Cavallaro J, Singha S, Chakrabarti B, Gopalakrishnan E, Harshan M, Pramanik BK, et al. Symptomatic infratentorial ependymal cyst arising from the medulla: a case report with review of literature. Neurochirurgie. 2024;70(4):101553.

van den Akker TA, Liu Y-, Liu H, Chapman J, Levine JM, Weinberg OK, et al. Myeloid Proliferations Associated with Down Syndrome: Clinicopathologic Characteristics of Forty Cases from Five Large Academic Institutions. Pathobiology. 2024;91(1):89-98.

2023

Agrawal P, David KA, Chen Z, Sundaram S, Kim S-, Vaca R, et al. EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort. Leuk Lymphoma. 2023;64(5):1026-1034.

Boyraz B, Watkins JC, Young RH, Oliva E. Uterine Tumors Resembling Ovarian Sex Cord Tumors: A Clinicopathologic Study of 75 Cases Emphasizing Features Predicting Adverse Outcome and Differential Diagnosis. Am J Surg Pathol. 2023;47(2):234-247.

Stagg J, Golden E, Wennerberg E, Demaria S. The interplay between the DNA damage response and ectonucleotidases modulates tumor response to therapy. Sci Immunol. 2023;8(85):eabq3015.